List of Adasuve drug patents

Adasuve is owned by Alexza Pharms.

Adasuve contains Loxapine.

Adasuve has a total of 7 drug patents out of which 2 drug patents have expired.

Expired drug patents of Adasuve are:

  • US6716416
  • US8074644

Adasuve was authorised for market use on 21 December, 2012.

Adasuve is available in powder;inhalation dosage forms.

The generics of Adasuve are possible to be released after 23 October, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6716416 ALEXZA PHARMS Delivery of antipsychotics through an inhalation route
May, 2022

(8 months ago)

US8074644 ALEXZA PHARMS Method of forming an aerosol for inhalation delivery
Jul, 2022

(6 months ago)

US9370629 ALEXZA PHARMS Self-contained heating unit and drug-supply unit employing same
May, 2024

(1 year, 3 months from now)

US8991387 ALEXZA PHARMS Self-contained heating unit and drug-supply unit employing same
May, 2024

(1 year, 3 months from now)

US7458374 ALEXZA PHARMS Method and apparatus for vaporizing a compound
Aug, 2024

(1 year, 6 months from now)

US7537009 ALEXZA PHARMS Method of forming an aerosol for inhalation delivery
Oct, 2024

(1 year, 8 months from now)

US8387612 ALEXZA PHARMS Self-contained heating unit and drug-supply unit employing same
Oct, 2026

(3 years from now)

Drugs and Companies using LOXAPINE ingredient

Market Authorisation Date: 21 December, 2012

Treatment: NA

Dosage: POWDER;INHALATION

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in